Abstract
BackgroundDiabetic retinopathy (DR) is one of the major complications of diabetes mellitus (DM) and the leading cause of blindness among adults. However, adherence to diabetic retinopathy screening (DRS) significantly reduces blindness. A substantial proportion of diabetics have suboptimal compliance to DRS, which inversely affects their outcomes. Therefore, the aim of this study is to determine the level of adherence to DRS and to explore the factors possibly associated with poor adherence to regular screening among diabetics in Riyadh, Saudi Arabia.MethodA cross-sectional study was conducted that encompassed 404 adult diabetic patients attending outpatient clinics in four hospitals in Riyadh. A validated, self-administered questionnaire was used for data collection that included five main sections: sociodemographic data, diabetic profile, assessment of knowledge about DR, attitude toward DRS, and barriers to DRS. Data were analyzed by SPSS, version 23 (IBM Corp., Armonk, NY); qualitative variables were described as percentages, and quantitative variables were described as means ± standard deviation (SD). We used the chi-square test to measure the associations between qualitative variables and binary logistic regression analysis to predict the independent barriers to DRS.ResultThe average age of the participants was 54 years, and 69.1% were females. The average duration of diabetes was 12.3 years. Type 2 DM was the most prevalent form of DM (63.6%). DR was reported by 20% of participants. Poor knowledge about DRS was prevalent in 51%. More than one-fifth were never screened for DR. About one-third of participants agreed that cost was an important contributing barrier. Adequate knowledge, increased duration of diabetes, and presence of neurological complications increased independent adherence to screening.ConclusionOne-fifth of participants reported having DR. Half the participants had poor knowledge about DR, which formed a major barrier against regular screening. However, most participants had positive attitudes about DR screening. Therefore, intervention strategies to increase patients’ awareness of DR might be the cornerstone of ensuring proper adherence to DRS.
Highlights
Diabetes mellitus (DM) is a chronic debilitating disease that constitutes a substantial problem in both developing and developed nations
The aim of this study is to determine the level of adherence to diabetic retinopathy screening (DRS) and to explore the factors possibly associated with poor adherence to regular screening among diabetics in Riyadh, Saudi Arabia
We calculated the sample size based on the expected level of awareness and adherence to DRS using the free G*Power online software
Summary
Diabetes mellitus (DM) is a chronic debilitating disease that constitutes a substantial problem in both developing and developed nations This disease is one of the major challenges facing health-care systems due to the remarkable financial burden associated with its multiple comorbidities and high mortality rates [1]. According to the International Diabetes Federation in 2017, the estimated number of people (18-99years old) living with diabetes amounted to 451 million, and it has been projected that the number of diabetics will increase to 693 million by 2045 [3]. The majority of these numerical increments will occur in developing countries [2]. The aim of this study is to determine the level of adherence to DRS and to explore the factors possibly associated with poor adherence to regular screening among diabetics in Riyadh, Saudi Arabia
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.